Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Expanded Access Policy for Investigational Drugs
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Kristina Sjöblom Nygren
May 21, 2018
Latest press releases
2025-04-07 09:40
Notice of Annual General Meeting of Infant Bacterial Therapeutics
Regulatory
2025-03-28 18:52
IBT is granted Breakthrough Therapy Designation for its Drug Candidate
Regulatory
MAR
2025-03-27 08:00
Infant Bacterial Therapeutics AB publishes the Annual Report for 2024
Regulatory
2025-02-13 08:30
Infant Bacterial Therapeutics AB (publ) Year-end report January 1 – December 31, 2024
Regulatory
2024-12-20 16:33
IBT Continues Development of Drug Candidate IBP-9414